FDA approves updated drug labeling for fludarabine phosphate under Project Renewal

Coverage, in order

1. 2d ago
   first FDA Drug Safety / Drugs feed indie

   FDA approves updated drug labeling for fludarabine phosphate under Project Renewal

   On November 19, 2024, the FDA approved updated drug labeling for fludarabine phosphate (Fludarabine Phosphate Injection, Sandoz) under Project Renewal, an Oncology Center of Excellence (OCE) initiative aimed at updating labeling information for certain older oncology drugs.

2. 2d ago
   FDA Drug Safety / Drugs feed indie

   FDA approves updated drug labeling including new indications and dosing regimens for capecitabine tablets under Project Renewal

   FDA approves updated drug labeling including new indications and dosing regimens for capecitabine tablets under Project Renewal

3. 1d ago
   FDA Drug Safety / Drugs feed indie

   FDA approves new and updated indications for temozolomide under Project Renewal

   On September 14, 2023, the Food and Drug Administration (FDA) approved updated labeling for temozolomide (Temodar, Merck) under Project Renewal, an Oncology Center of Excellence (OCE) initiative aimed at updating labeling information for older oncology drugs to ensure information is clinically meani

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.